Catheter based treatments for fibrosing mediastinitis.
Erin Amanda FenderR Jay WidmerErica M Knavel KoepselJohn P WelbyRyan KernTobias PeikertHaraldur BjarnasonDavid R HolmesPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Fibrosing mediastinitis is a rare, often debilitating and potentially lethal disease characterized by an exuberant fibroinflammatory response within the mediastinum. Patients typically present with insidious symptoms related to compression of adjacent structures including the esophagus, heart, airways, and cardiac vessels. Fibrosing mediastinitis is most often triggered by Histoplasmosis infection; however, antifungal and anti-inflammatory therapies are largely ineffective. While structural interventions aimed at alleviating obstruction can provide significant palliation, surgical interventions are challenging with high mortality and clinical experience with percutaneous interventions is limited. Here, we will review the presentation, natural history, and treatment of fibrosing mediastinitis, placing particular emphasis on catheter-based therapies.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- physical activity
- end stage renal disease
- ultrasound guided
- anti inflammatory
- newly diagnosed
- ejection fraction
- rheumatoid arthritis
- chronic kidney disease
- heart failure
- cystic fibrosis
- idiopathic pulmonary fibrosis
- peritoneal dialysis
- left ventricular
- cardiovascular disease
- atrial fibrillation
- cardiovascular events
- candida albicans
- type diabetes
- risk factors
- case report